|
Mount Carmel has an active research program that involves dozens of clinical trials sponsored by top pharmaceutical companies and the National Cancer Institute (NCI). As a result, many Mount Carmel patients have the opportunity to enroll in clinical trials offering new or advanced treatments. Among these are new drugs, contemporary drug combinations, innovative devices and pioneering treatment programs. By participating in a clinical trial, patients can receive the most advanced care while helping researchers uncover new ways to treat disease.
Our investigators are conducting more than 100 active research protocols. Mount Carmel also has access to over 150 NCI-sponsored clinical trials and other oncology cooperative programs.
Mount Carmel's charter membership in the Columbus Community Clinical Oncology Program (CCCOP) allows participating physicians and their patients access to clinical trials through affiliations with national research cooperative groups. We also support industry-sponsored Investigational New Drug (IND) and Investigational Device Exemption (IDE) trials, which are designed to study new drug therapies and new medical devices.
Our major areas of investigation include Heart & Vascular Clinical Trials, Obstetrics & Gynecology Clinical Trials, Oncology Clinical Trials and Surgery Clinical Trials.
View our complete listing of current clinical trials.
In most of the studies, medical evaluation, medical care and study medication would be provided at no cost to the participants. You may also be reimbursed for travel expenses; however, reimbursement, requirements and contact information vary by study.
Mount Carmel has been successfully enrolling patients in clinical trials for over 20 years, and continues to exceed the "commendable" standard set by the American College of Surgeons. For more information about clinical trials at Mount Carmel or to enroll, please review the study-specific information provided in the links above.
|
